Integrative analysis based on survival associated co-expression gene modules for predicting Neuroblastoma patients’ survival time

Abstract excerpt

BACKGROUND: More than 90% of neuroblastoma patients are cured in the low-risk group while only less than 50% for those with high-risk disease can be cured. Since the high-risk patients still have poor outcomes, we need more accurate stratification to establish an individualized precise treatment plan for the patients to improve the long-term survival rate. RESULTS: We focus on extracting features and providing a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clusterin in disease pathology
• Share to Ferroptosis and cancer prognosis
• Share to Neuroblastoma Research and Treatments